Randhawa Simrat - Insider Non-Derivative Transactions at Dianthus Therapeutics, Inc. /DE/ (DNTH) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 14, 2025, Randhawa Simrat's relationship to Dianthus Therapeutics, Inc. /DE/ (DNTH) is Officer (EVP, Head of R&D), and currently has 113,031 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other DNTH insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Randhawa Simrat - Insider Non-Derivative Transactions of DNTH Common Stock

Randhawa Simrat - Insider Non-Derivative Transactions at DNTH

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 15, 2025	Sell -- (Common Stock)	109031	38.14	4000
Nov 15, 2025	M -- (Common Stock)	40287	17.88	44287
Nov 15, 2025	M -- (Common Stock)	37494	21.77	81781
Nov 15, 2025	M -- (Common Stock)	31250	22.07	113031
Nov 14, 2025	Sell -- (Common Stock)	18576	37.72	4000
Nov 14, 2025	Sell -- (Common Stock)	42765	37.04	22576
Nov 14, 2025	Sell -- (Common Stock)	26166	35.8	65341
Nov 14, 2025	M -- (Common Stock)	83978	8.44	87978
Nov 14, 2025	M -- (Common Stock)	3529	17.88	91507
Sep 23, 2023	P -- (Common Stock)	2000	13.2	4000
Sep 22, 2023	P -- (Common Stock)	2000	13.2	2000